Cephalon wins U.S. approval for leukemia drug (Reuters)Reuters - Cephalon Inc won U.S. approval to
sell a chemotherapy drug to treat patients with a slow-growing
type of leukemia, the company said on Thursday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cephalon_treanda_dc.html